CLINICAL_TRIALS
trial_result
· 2011-07-04
Clinical Trial Update: Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab [Phase 4]
Summary
Phase 4 trial examining immunophenotyping of peripheral T cells after T cell depletion with alemtuzumab in kidney transplant patients; study terminated with res…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Kidney Transplant | Phase 4 | Status: TERMINATED | Results posted: 2011-07-04